, Tracking Stock Market Picks
Enter Symbol:
Regeneron Pharmaceuticals, Inc. (REGN) [hlAlert]

up 1,826.93 %

Regeneron Pharmaceuticals, Inc. (REGN) rated Overweight with price target $72 by Barclays Capital

Posted on: Friday,  Apr 29, 2011  12:25 PM ET by Barclays Capital

Barclays Capital rated Overweight Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on 04/29/2011. Previously Barclays Capital rated Overweight Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on
10/25/2010., when the stock price was $27.92. Since then, Regeneron Pharmaceuticals, Inc. has gained 1826.93% as of 01/27/2016's recent price of $538.00.
If you would have followed the previous Barclays Capital's recommendation on REGN, you would have gained 1826.93% of your investment in 1920 days.

Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic drugs for thetreatment of serious medical conditions. Regeneron's platform technologies include Targeted GenomicsTM, FunctionomicsTM, and Designer Protein TherapeuticsTM. Regeneron has drugs in clinical and preclinical development for the potential treatment of obesity, rheumatoid arthritis, cancer, allergies, asthma, amyotrophic lateral sclerosis, constipating conditions, ischemia, and other diseases and disorders. (PRESS RELEASE)

Barclays Capital has assembled a world-class, award-winning team of analysts covering, credit, commodities, economics, emerging markets, equities, fixed income, foreign exchange and market strategy. We provide in-depth analysis of companies and macro coverage across asset classes, markets and the world’s economies. We have a highly quantitative approach and our research is underpinned by sophisticated analytics. Combined, these provide clients with the tools and insights necessary for successful risk management and financing. Our research teams are based in many of the world’s major financial centres providing our clients with a globally integrated perspective across products and geographies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/29/2011 12:25 PM Buy
58.21 72.00
as of 12/30/2011
1 Week down  -0.25 %
1 Month down  -6.71 %
3 Months down  -4.75 %
1 YTD up  68.83 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/27/2011 1:25 PM Buy
69.73 64.00
4/13/2011 12:25 PM Buy
45.00 56.00
11/22/2010 3:25 PM Buy
28.78 48.00
10/25/2010 1:25 PM Buy
27.92 38.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy